Gagnon Securities’s Chembio diagnostics, Inc. CEMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-47,793
Closed -$119K 116
2021
Q3
$119K Sell
47,793
-232
-0.5% -$644 0.02% 112
2021
Q2
$143K Sell
48,025
-47
-0.1% -$164 0.02% 108
2021
Q1
$169K Sell
48,072
-57
-0.1% -$317 0.03% 103
2020
Q4
$229K Buy
48,129
+7,278
+18% +$37.6K 0.04% 90
2020
Q3
$199K Sell
40,851
-31
-0.1% -$147 0.04% 86
2020
Q2
$133K Buy
+40,882
New +$388K 0.03% 84
2020
Q1
Sell
-321,394
Closed -$1.47M 104
2019
Q4
$1.47M Sell
321,394
-106
-0% -$517 0.32% 44
2019
Q3
$1.97M Buy
321,500
+18,211
+6% +$109K 0.47% 41
2019
Q2
$1.85M Buy
303,289
+1,162
+0.4% +$7.84K 0.4% 45
2019
Q1
$1.68M Sell
302,127
-3,095
-1% -$20.1K 0.37% 43
2018
Q4
$1.73M Buy
305,222
+42,157
+16% +$311K 0.46% 40
2018
Q3
$2.76M Sell
263,065
-829
-0.3% -$8.9K 0.63% 32
2018
Q2
$2.93M Buy
263,894
+62,196
+31% +$560K 0.84% 29
2018
Q1
$1.61M Buy
+201,698
New +$1.61M 0.57% 33

Other funds holding CEMI

Gagnon Securities's CEMI Position: Q4 2021 in Review

Gagnon Securities sold out of Chembio diagnostics, Inc. (CEMI) in Q4 2021, closing a stake of 47,793 shares — an estimated $119K sold.

Gagnon Securities first reported a position in CEMI in Q1 2018 and held it in 14 quarters. The position peaked at $2.93M in Q2 2018. 43 funds tracked by Wall St. Rank hold CEMI as of Q4 2021.

  • Gagnon Securities reported no remaining Chembio diagnostics, Inc. position as of Q4 2021 after selling out during the quarter.
  • Gagnon Securities sold 47,793 Chembio diagnostics, Inc. shares in Q4 2021, an estimated $119K.
  • Gagnon Securities first reported a position in Chembio diagnostics, Inc. in Q1 2018 and held it in 14 quarters.
  • Gagnon Securities's Chembio diagnostics, Inc. position peaked at $2.93M in Q2 2018.
  • 43 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2021.

Based on Gagnon Securities's 13F filing for Q4 2021, filed 8 Feb 2022.